论文部分内容阅读
临床上治疗失眠,通常采用催眠药与镇静药。这类药不但有明显的肝损害、粒细胞减少等副作用,而且长期使用可出现依赖性和反跳现象。笔者在1998年7月至1999年7月以氯酯醒合用舒乐安定治疗失眠取得良效,现报告如下。1 临床资料1.1 病例选择 把有入睡困难、睡眠时间短、醒转多等表现的188例失眠病人,随机分成两组:氯酯醒合用舒乐安定组(治疗组)120例,男68例,女52例,年龄42±12岁,病程2±0.5年。舒乐安定组(对照组)68例,男35例,女33例,年龄42±12岁,病程2±0.5年。两组病人的病程和年龄差异无统计学意义(P>0.05)。
Clinical treatment of insomnia, hypnotics and sedatives are usually used. Such drugs not only have obvious liver damage, neutropenia and other side effects, but also the long-term use of dependence and rebound phenomenon. The author in July 1998 to July 1999 to chlorine ester awake with lelerazoline treatment of insomnia achieved good results, are as follows. 1 Clinical data 1.1 Case Selection 188 insomnia patients with difficulty falling asleep, short sleep, wake up and more were randomly divided into two groups: 120 cases of chlorphenylacetic acid and celecoxib group (treatment group), 68 males, Female 52 cases, age 42 ± 12 years, duration 2 ± 0.5 years. Shuilean stability group (control group) 68 cases, 35 males and 33 females, aged 42 ± 12 years, duration of 2 ± 0.5 years. There was no significant difference in the course and age between the two groups (P> 0.05).